Chimerix Owners | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Chimerix Inc.

Chimerix Inc. | Ownership

Companies that own Chimerix Inc.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Fidelity Management & Research Co.

4,525,570

9.48%

-400,709

08/31/2018

ArrowMark Colorado Holdings LLC

3,898,937

8.16%

754,716

0.14%

06/30/2018

Redmile Group LLC

3,589,490

7.52%

-139,200

0.44%

06/30/2018

BlackRock Fund Advisors

3,235,925

6.78%

14,250

06/30/2018

Dimensional Fund Advisors LP

2,481,614

5.2%

164,472

06/30/2018

The Vanguard Group, Inc.

1,953,020

4.09%

43,744

06/30/2018

Morgan Stanley & Co. LLC

1,572,078

3.29%

606,015

0.01%

06/30/2018

Armistice Capital LLC

1,258,000

2.63%

226,800

0.38%

06/30/2018

Opaleye Management, Inc.

1,150,000

2.41%

550,000

1.15%

06/30/2018

Numeric Investors LLC

935,644

1.96%

-93,791

0.02%

06/30/2018

About Chimerix

View Profile

Address	2505 Meridian Parkway Durham North Carolina 27713 United States
Employees	-
Website	http://www.chimerix.com
Updated	07/08/2019
Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded by George R.